KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,334 | -45.0% | 3,837 | -9.0% | 0.03% | -43.9% |
Q2 2023 | $96,903 | -4.3% | 4,215 | +23.3% | 0.06% | +1.8% |
Q1 2023 | $101,305 | -14.2% | 3,419 | -27.7% | 0.06% | -9.7% |
Q4 2022 | $118,036 | -24.8% | 4,729 | -34.5% | 0.06% | -1.6% |
Q3 2022 | $157,000 | +11.3% | 7,222 | +0.7% | 0.06% | +21.2% |
Q2 2022 | $141,000 | +14.6% | 7,171 | +147.4% | 0.05% | -5.5% |
Q1 2022 | $123,000 | -36.9% | 2,898 | -5.6% | 0.06% | -25.7% |
Q4 2021 | $195,000 | -21.1% | 3,071 | -27.0% | 0.07% | -32.1% |
Q3 2021 | $247,000 | +15.4% | 4,205 | -4.9% | 0.11% | +23.9% |
Q2 2021 | $214,000 | – | 4,421 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
AtonRa Partners | 19,172 | $266,491 | 0.56% |
Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |